Applied Therapeutics
Latest round
- Series A
Last raised
- Jan 2017
Total raised
- $6.1M
Investors
- 4
About Applied Therapeutics
Based in New York, US, and founded by Shoshana Shendelman (CEO) in 2017, Applied Therapeutics, Inc. operates as a biopharmaceutical company specializing in providing Aldose Reductase Inhibitor (ARI) for diseases. The is trading under the NASDAQ stock exchange under the ticker symbol APLT. Utilizing technological advances and leveraging FDA guidance on biomarkers, Applied Therapeutics aims to expedite the development process, bringing treatments to market for patients with high unmet medical needs. The company's pipeline includes Aldose Reductase Inhibitors (ARI) designed for conditions like Galactosemia, SORD Deficiency, PMM2-CDG, Diabetic Peripheral Neuropathy, Diabetic Rentinopathy, and Diabetic Cardiomyopathy, with ongoing clinical trials demonstrating phase 1 to phase 3 results. Applied Therapeutics’s preclinical pipeline also includes a PI3 kinase inhibitor in development for orphan oncology indications.
Who invested in Applied Therapeutics
4 investors across 1 round
See all investors in Applied Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 26, 2017
Amount
$6.1M
Investors
Questions about Applied Therapeutics
Who invested in Applied Therapeutics?
Applied Therapeutics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Applied Therapeutics raised?
Applied Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Applied Therapeutics last raise money?
Applied Therapeutics's most recent round on record is a Series A, in Jan 2017.
What does Applied Therapeutics do?
Based in New York, US, and founded by Shoshana Shendelman (CEO) in 2017, Applied Therapeutics, Inc.
Where is Applied Therapeutics headquartered?
Applied Therapeutics is headquartered in New York, US.
Which VCs invest in companies like Applied Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Applied Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Applied Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.